The FIFARMA annual Regional Meeting was held in Miami between May 23rd and 24th 2017. FIFARMA member Companies and Local Associations gathered together to review the activities developed by FIFARMA in the last year, and also to discuss FIFARMA’s strategy for the following year.
The first day started with a brief joint presentation by PhRMA, BIO and FIFARMA in which the main priorities in LATAM and the areas of common work and collaboration were highlighted. Afterwards, Local Associations had the opportunity of discussing activities and priorities with the Co-Chairs of the FIFARMA Working Groups in order to ensure alignment and pertinence of the FIFARMA regional strategy at a local level.
In the afternoon a discussion on Healthcare Sustainability was developed, which was initiated by the presentation of the Puerto Rico experience with the SUSI (Sustainable Strategic Initiative) project made by Ivan Roman, PIA Director. Afterwards, the participants discussed strategies to develop a healthcare sustainable model locally in each Local Association.
At the end of the first day, the representatives of the majority of the companies and associations signed the commitment to adhere to the Pharma Integrity principles, a project developed by Transparency International and FIFARMA.
The participation of guest speakers allowed the consideration of topics that are of pertinence for the industry currently. Dr. Juan Francisco Millan from Cetifarma shared the experience with compliance in Mexico, Chrisoula Nikidis from APEC presented APEC activities on compliance and ethics, Ramiro Gilardino from ISPOR mentioned the activities that ISPOR is doing in Latam and finally Thomas O Keefe from Mercosur Consulting group, provided a brief update of the current initiatives of pooled procurement in the region.
In the second part of the afternoon, Rodney Lopez from MSD, did a presentation about counterfeiting in LATAM, a topic of high relevance to the industry and the healthcare authorities in the region. This was followed by a short presentation on the participation of FIFARMA in the Fight the Fakes Campaign from IFPMA, a campaign that aims at creating awareness about the impact and the damage of fake medicines in patients. Finally, Luis Villalba FIFARMA Director General did a brief update of the TI-FIFARMA code of conduct project and closed the meeting.
The meeting opened a space to discuss FIFARMA initiatives and main goals to implement the strategy for 2017-2018.